4-Aminopyridine in Episodic Ataxia Type 2

NCT01543750 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Episodic Ataxia Type 2

Interventions

DRUG: 4-Aminopyridine
DRUG: Placebo

Sponsor

University of California, Los Angeles

Collaborators

[object Object]
[object Object]